Jane Street’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,783,950
Closed -$7.57M 11464
2025
Q4
$6.44M Buy
1,783,950
+1,503,751
+537% +$6.56M ﹤0.01% 2878
2025
Q3
$1.06M Buy
+280,199
New +$1.08M ﹤0.01% 6194
2025
Q2
Sell
-152,642
Closed -$826K 9529
2025
Q1
$763K Sell
152,642
-126,008
-45% -$798K ﹤0.01% 6067
2024
Q4
$2.01M Sell
278,650
-104,013
-27% -$795K ﹤0.01% 4091
2024
Q3
$2.35M Buy
382,663
+246,412
+181% +$1.67M ﹤0.01% 4143
2024
Q2
$906K Buy
136,251
+34,674
+34% +$256K ﹤0.01% 5950
2024
Q1
$1.03M Sell
101,577
-478,867
-83% -$4.87M ﹤0.01% 5351
2023
Q4
$6.53M Buy
580,444
+521,495
+885% +$2.18M ﹤0.01% 2486
2023
Q3
$153K Sell
58,949
-231,327
-80% -$664K ﹤0.01% 7770
2023
Q2
$1.02M Buy
290,276
+107,521
+59% +$483K ﹤0.01% 5154
2023
Q1
$771K Sell
182,755
-62,388
-25% -$741K ﹤0.01% 5523
2022
Q4
$4.03M Buy
245,143
+14,580
+6% +$164K ﹤0.01% 2778
2022
Q3
$2.94M Buy
230,563
+186,349
+421% +$2.75M ﹤0.01% 3491
2022
Q2
$517K Sell
44,214
-2,520
-5% -$15.5K ﹤0.01% 6679
2022
Q1
$285K Buy
46,734
+8,680
+23% +$63.9K ﹤0.01% 8471
2021
Q4
$349K Buy
38,054
+16,337
+75% +$174K ﹤0.01% 7897
2021
Q3
$245K Sell
21,717
-163,087
-88% -$1.98M ﹤0.01% 8542
2021
Q2
$1.82M Buy
184,804
+90,775
+97% +$1.24M ﹤0.01% 4505
2021
Q1
$1.33M Buy
94,029
+63,204
+205% +$1.02M ﹤0.01% 4874
2020
Q4
$348K Buy
+30,825
New +$363K ﹤0.01% 6206
2019
Q1
Sell
-10,301
Closed -$21K 4953
2018
Q4
$21K Buy
+10,301
New +$36.5K ﹤0.01% 4789
2013
Q3
Sell
-353
Closed -$168K 2677
2013
Q2
$168K Buy
+353
New +$175K ﹤0.01% 2309

Other funds holding ALT

Jane Street's ALT Position: Q1 2026 in Review

Jane Street sold out of Altimmune (ALT) in Q1 2026, closing a stake of 1,783,950 shares — an estimated $7.57M sold.

Jane Street first reported a position in ALT in Q2 2013 and held it in 22 quarters. The position peaked at $6.53M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Jane Street reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,783,950 Altimmune shares in Q1 2026, an estimated $7.57M.
  • Jane Street first reported a position in Altimmune in Q2 2013 and held it in 22 quarters.
  • Jane Street's Altimmune position peaked at $6.53M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.